Related Experiment Video
Updated: Jun 14, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Malignant mesothelioma of the peritoneum: case reports and immunohistochemical findings including Ki-67 expression
Hiroshi Hirano1, Takashi Fujisawa, Koichi Maekawa
1Department of Pathology, Nippon Steel Hirohata Hospital, 3-chome, Yumesakicho, Hirohata-ku, Himeji, Hyogo, 671-1122, Japan. h_hirano@hirohata-hp.or.jp
Abstract:
A malignant mesothelioma (MM) is an aggressive neoplasm, although some patients have shown long-term survival, and factors related to survival remain uncertain. We present three cases of MM of the peritoneum including autopsy results, in which factors related to long-term survival were investigated. Case 1 was a 69-year-old man who died 6 years after the initial diagnosis. In case 2, a 67-year-old woman came to us with abdominal distention and, despite chemotherapy, died 9 months after the initial diagnosis. The patient in case 3 was a 68-year-old man who also had abdominal distention and died 9 months after the initial diagnosis. We studied the clinicopathological appearance and performed immunohistochemical staining including Ki-67 labeling index (Ki-67 LI) in primary and metastatic sites of these cases. The histological findings of case 1 indicated epithelioid type; case 2 and 3 were of biphasic type. Immunohistochemical results were consistent with MM. The Ki-67 LI value for both primary and metastatic sites of case 1 was significantly lower than those in cases 2 and 3. We consider Ki-67 LI to be a useful prognostic indicator for MM of the peritoneum.
Insights
Malignant mesothelioma (MM) survival factors are unclear. This study found a lower Ki-67 labeling index (LI) in peritoneal MM cases with longer survival, suggesting it
Area of Science:
- Oncology
- Pathology
Background:
- Malignant mesothelioma (MM) is an aggressive cancer.
- Long-term survival factors in peritoneal MM remain uncertain.
Observation:
- Three peritoneal MM cases with autopsy results were analyzed.
- Clinicopathological appearance and immunohistochemical staining were performed.
- Ki-67 labeling index (LI) was assessed in primary and metastatic sites.
Findings:
- Case 1 (epithelioid MM) survived 6 years with a low Ki-67 LI.
- Cases 2 & 3 (biphasic MM) survived 9 months with high Ki-67 LI.
- Lower Ki-67 LI correlated with longer survival in peritoneal MM.
Implications:
- Ki-67 LI may serve as a prognostic indicator for peritoneal MM.
- Further research into MM prognostic markers is warranted.
- Understanding survival factors can guide treatment strategies.

